Latest News - GE HealthCare Technologies
Top Corporates Hub
GE HealthCare Technologies
GE HealthCare advances Signa MRI portfolio with trio of FDA clearances
20.02.2026 12:29
The FDA clearance of GE HealthCare’s next-generation Signa products aligns with the company’s multi-year strategy to differentiate its MRI portfolio.
Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel
17.02.2026 16:20
TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.
QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement
17.02.2026 16:12
QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.
GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness
17.02.2026 14:00
CHICAGO, February 17, 2026--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded
GE HealthCare Technologies Inc. (GEHC) Expands Healthcare Technology Offerings
15.02.2026 11:53
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best medical technology stocks to invest in. On February 12, GE HealthCare Technologies Inc.’s (NASDAQ:GEHC) board declared a $0.035 per share cash dividend Q1 2026. The dividend will be disbursed on May 15, 2026, to shareholders of record as of April 3, 2026. This dividend amount […]
GE HealthCare’s New ECG And AI Imaging Tools Reshape Growth Story
15.02.2026 01:08
GE HealthCare Technologies (NasdaqGS:GEHC) has launched ReadyFix, a remote fleet management solution focused on ECG devices, aimed at improving device uptime and configuration across large hospital networks. The company also received FDA clearance and CE Marking for Allia Moveo, a compact AI powered interventional imaging system designed to support complex procedures with greater mobility and workflow integration. For investors watching GE HealthCare at a share price of $80.34, these...
GE HealthCare management to present at upcoming investor conferences
12.02.2026 12:30
CHICAGO, February 12, 2026--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.
GEHC or SYK: Which Is the Better Value Stock Right Now?
11.02.2026 16:40
GEHC vs. SYK: Which Stock Is the Better Value Option?
5 Must-Read Analyst Questions From GE HealthCare’s Q4 Earnings Call
11.02.2026 05:36
GE HealthCare’s fourth quarter saw positive momentum, with the company surpassing Wall Street’s revenue and non-GAAP profit expectations. Management pointed to robust demand in pharmaceutical diagnostics and steady growth in imaging and advanced visualization solutions as key drivers. CEO Peter Arduini highlighted progress in bringing new products to market, including successful launches in Europe and advanced cardiovascular ultrasound systems. The company also benefited from large enterprise ag
Is GE HealthCare Technologies (GEHC) Offering Value After Recent Share Price Weakness
05.02.2026 02:11
If you are wondering whether GE HealthCare Technologies is priced attractively right now or if the current share price already reflects its potential, this article walks you through what the numbers are saying about value. The stock last closed at US$82.58, with returns of 4.2% over the past week, a 2.9% decline over the last 30 days, a 0.3% decline year to date, and a 5.1% decline over the past year, while the 3 year return sits at 18.3%. Recent attention on GE HealthCare has been supported...
GE HealthCare (GEHC) Q4 2025 Earnings Transcript
04.02.2026 15:12
As I look back on our performance in 2025, our third year as a public company, I'm incredibly proud of the meaningful progress that we're making on our innovation renaissance to deliver for our customers and improve patient lives. In the fourth quarter, we delivered strong financial performance above our expectations. The overall capital equipment environment remained healthy.
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates
04.02.2026 12:30
GE HealthCare (GEHC) delivered earnings and revenue surprises of +1.00% and +1.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
04.02.2026 12:24
Feb 4 (Reuters) - GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for its diagnostic and imaging devices.
GE HealthCare Technologies (GEHC) Valuation Check As Earnings Near And Allia Moveo Launch Gains Attention
04.02.2026 12:14
GE HealthCare Technologies (GEHC) heads into its upcoming earnings report with attention on two fronts: the expected 5.3% revenue growth to US$5.60b and fresh regulatory milestones for its Allia Moveo imaging system. See our latest analysis for GE HealthCare Technologies. Despite a stream of product and partnership updates, including the Allia Moveo clearances and the new anesthesia collaboration with U.S. Anesthesia Partners, the share price has slipped recently, with a 30 day share price...
GE HealthCare Stock Rises. Why Earnings Were a Relief.
04.02.2026 12:03
Wednesday, GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion.
GE HealthCare offers forecast-beating profit outlook after Q4 beat
04.02.2026 12:01
Investing.com -- GE HealthCare (NASDAQ:GEHC) reported fourth-quarter results that beat analyst expectations, and offered 2026 profit guidance that also exceeded consensus estimates.
GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue
04.02.2026 11:46
GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic environment.
GE HealthCare’s (NASDAQ:GEHC) Q4 CY2025: Beats On Revenue
04.02.2026 11:36
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.1% year on year to $5.70 billion. Its non-GAAP profit of $1.44 per share was 3% above analysts’ consensus estimates.
GE HealthCare: Q4 Earnings Snapshot
04.02.2026 11:35
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.43 per share. The medical technology company posted revenue of $5.7 billion in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $5.59 billion.
GE HealthCare reports fourth quarter and full year 2025 financial results
04.02.2026 11:20
CHICAGO, February 04, 2026--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025.